RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
Recruiting · NCT05256745 · Registry updated 2025-12-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer | Cancer Related Cognitive Decline; Non-metastatic Breast Cancer | Recruiting | Phase 1 / Phase 2 | 2025-12-24 | NCT05256745 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Georgetown University | 73 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Georgetown Lombardi Comprehensive Cancer Center | Washington D.C. | United States | 14 |
| John Theurer Cancer Center at Hackensack University Medical Center | Hackensack | United States | 37 |
| MedStar Washington Hospital Center | Washington D.C. | United States | 207 |